-
Study aim
-
The effectiveness of exosomes into cesarean scar at the time of laparoscopic niche repair.
-
Design
-
This is a randomized triple-blind ,placebo control, phase 3 clinical trial involving a total of 60 patients; 30 patients in the case group allocated to 30 patients in the control group. For randomization, 30 "A" labels and 30 "B" labels covered in envelopes are placed in a box. For each patient an evelope is drawn out of the box. The physician, the patients, and the data analyst are be blinded to groups assignments.
-
Settings and conduct
-
This randomized, triple-blinded,placebo controlled ,clinical trial with a case group (exosomes injection) control group (sterile water injection ) will be conducted at the operation room of Yas Hospital. Random allocation will be used regarding case and control groups. The patients, physician, and data analysts will be blinded to the group assignments.
-
Participants/Inclusion and exclusion criteria
-
Patients with niche who are candidate for laparoscopic repair.
Inclusion critria:
Patients with niche and infertility,Patients with niche and pelvic pain,Patients with niche and AUB,Patients with niche and recurrent implantation failure
Exclusion criteria:
Patients who are not candidate for laparoscopic surgery
-
Intervention groups
-
This randomized, triple-blinded,placebo controlled ,clinical trial with a case group (exosomes injection) control group (sterile water injection ) will be conducted at the operation room of Yas Hospital. Random allocation will be used regarding case and control groups. The patients, physician, and data analysts will be blinded to the group assignments.
-
Main outcome variables
-
Evaluation of niche by transvaginal sonogram.